Portage Biotech Inc.

NasdaqCM:PRTG Stock Report

Market Cap: US$4.7m

Portage Biotech Management

Management criteria checks 4/4

Portage Biotech's CEO is Ian Walters, appointed in May 2019, has a tenure of 5.5 years. total yearly compensation is $717.89K, comprised of 89.5% salary and 10.5% bonuses, including company stock and options. directly owns 1.44% of the company’s shares, worth $68.39K. The average tenure of the management team and the board of directors is 2.8 years and 5.5 years respectively.

Key information

Ian Walters

Chief executive officer

US$717.9k

Total compensation

CEO salary percentage89.5%
CEO tenure5.5yrs
CEO ownership1.4%
Management average tenure2.8yrs
Board average tenure5.5yrs

Recent management updates

Recent updates

Portage Biotech GAAP EPS of -$0.13

Aug 29

Portage Biotech rises after getting full ownership of its anti-cancer agonist platform

Jul 20

Portage Biotech acquires Tarus Therapeutics, a developer of adenosine receptor antagonists

Jul 06

CEO Compensation Analysis

How has Ian Walters's remuneration changed compared to Portage Biotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$71m

Mar 31 2024US$718kUS$643k

-US$75m

Dec 31 2023n/an/a

-US$145m

Sep 30 2023n/an/a

-US$113m

Jun 30 2023n/an/a

-US$109m

Mar 31 2023US$2mUS$624k

-US$105m

Dec 31 2022n/an/a

-US$17m

Sep 30 2022n/an/a

-US$14m

Jun 30 2022n/an/a

-US$16m

Mar 31 2022US$3mUS$459k

-US$17m

Dec 31 2021n/an/a

-US$21m

Sep 30 2021n/an/a

-US$19m

Jun 30 2021n/an/a

-US$18m

Mar 31 2021US$6mUS$369k

-US$16m

Dec 31 2020n/an/a

-US$6m

Sep 30 2020n/an/a

-US$6m

Jun 30 2020n/an/a

-US$5m

Mar 31 2020US$350kUS$350k

-US$5m

Dec 31 2019n/an/a

-US$6m

Sep 30 2019n/an/a

-US$5m

Jun 30 2019n/an/a

-US$4m

Mar 31 2019US$202kn/a

-US$3m

Dec 31 2018n/an/a

US$124m

Sep 30 2018n/an/a

US$124m

Jun 30 2018n/an/a

US$124m

Mar 31 2018US$99kn/a

US$124m

Compensation vs Market: Ian's total compensation ($USD717.89K) is about average for companies of similar size in the US market ($USD652.28K).

Compensation vs Earnings: Ian's compensation has been consistent with company performance over the past year.

CEO

Ian Walters (56 yo)

5.5yrs

Tenure

US$717,885

Compensation

Dr. Ian B. Walters, M.D. M.B.A. has been Chairman of the Board at Portage Biotech Inc. since August 2022. He has been the Chief Executive Officer of Portage Biotech Inc. since May 1, 2019 and has been its...

Leadership Team

NamePositionTenureCompensationOwnership
Ian Walters
CEO & Chairman of Board5.5yrsUS$717.89k1.44%
$ 68.4k
Robert Kramer
Chief Scientific Officer5.8yrsUS$185.89k0.67%
$ 31.8k
Brian Wiley
Chief Business Officer2.8yrsUS$155.42kno data
Eun-Jae Park
Chief Financial Officerless than a yearno datano data
Adam Melero
Controllerless than a yearno datano data

2.8yrs

Average Tenure

56yo

Average Age

Experienced Management: PRTG's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Ian Walters
CEO & Chairman of Board8.3yrsUS$717.89k1.44%
$ 68.4k
Jean-Christophe Renondin
Directorless than a yearno datano data
Gregory Bailey
Independent Lead Director11.4yrsUS$49.50k9.63%
$ 456.6k
Steven Mintz
Independent Director8.6yrsUS$45.75k0.26%
$ 12.5k
James Mellon
Independent Director2.8yrsUS$35.24k13.98%
$ 662.6k
Justin Stebbing
Directorless than a yearno datano data

5.5yrs

Average Tenure

63yo

Average Age

Experienced Board: PRTG's board of directors are considered experienced (5.5 years average tenure).